Publications by authors named "Kevin C Mange"

Claim this Profile
P
Psychometric validation of the PROMIS Fatigue-Short Form 7a in adults with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease: the ARISE and ENCORE studies.
Kevin C Mange, Daniel Serrano, Mariam Hassan, Marie-Laure Nevoret, Dayton W Yuen

J Patient Rep Outcomes· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease.
Kelly P McCarrier, Mariam Hassan, Dayton W Yuen, Jui-Hua Tsai, Nancy Touba, Kevin C Mange

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
David Cipolla, Jimin Zhang, Brice Korkmaz, James D Chalmers, Jessica Basso, Kevin C Mange

Respir Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
James D Chalmers, Helen Usansky, Christopher M Rubino, Ariel Teper, Carlos Fernandez, Kevin C Mange

Clin Pharmacokinet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin liposome inhalation suspension clinical benefit-risk assessment for refractory complex lung disease.
Theodore K Marras, Mariam Hassan, Kevin C Mange, Monika Ciesielska, Shilpa Dhar Murthy

ERJ Open Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.
Christina M Mingora, Bryan A Garcia, Kevin C Mange, Dayton W Yuen, Monika Ciesielska

BMC Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
D Rebecca Prevots, Theodore K Marras, Ping Wang, Kevin C Mange, Patrick A Flume

Chest· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
David E Griffith, Rachel Thomson, Patrick A Flume, Timothy R Aksamit, Stephen K Field, Kevin C Mange

Chest· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin Liposome Inhalation Suspension for Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial.
Kevin L Winthrop, Patrick A Flume, Rachel Thomson, Kevin C Mange, Dayton W Yuen

Ann Am Thorac Soc· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease.
Christopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, David E Griffith, Sujata M Bhavnani, Kevin C Mange

Eur J Drug Metab Pharmacokinet· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease.
Christopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, David E Griffith, Sujata M Bhavnani, Kevin C Mange

Eur J Drug Metab Pharmacokinet· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
James D Chalmers, Charles S Haworth, Mark L Metersky, Michael R Loebinger, Francesco Blasi, Kevin C Mange

N Engl J Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo therapy with everolimus and reduced-exposure cyclosporine following pediatric kidney transplantation: a prospective, multicenter, 12-month study.
Carl Grushkin, John D Mahan, Kevin C Mange, J Mark Hexham, Robert Ettenger

Pediatr Transplant· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients.
Hans B Lehmkuhl, José Arizon, Mario Viganò, Luis Almenar, Gino Gerosa, Kevin C Mange

Transplantation· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of completion of the medical evaluation for renal transplantation.
Francis L Weng, Marshall M Joffe, Harold I Feldman, Kevin C Mange

Am J Kidney Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation.
Francis L Weng, Ajay K Israni, Marshall M Joffe, Tracey Hoy, Christina A Gaughan, Kevin C Mange

J Am Soc Nephrol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival.
Ajay K Israni, Harold I Feldman, Kathleen J Propert, Mary Leonard, Kevin C Mange

Am J Transplant· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function.
Kevin C Mange, Eline Luning Prak, Malek Kamoun, Yangzhu Du, Noah Goodman

Kidney Int· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allograft survival following adult-to-adult living donor liver transplantation.
Peter L Abt, Kevin C Mange, Kim M Olthoff, James F Markmann, K Rajender Reddy

Am J Transplant· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges from bias when estimating change of renal allograft function.
Kevin C Mange

Kidney Int· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients.
Ergun Velidedeoglu, Kevin C Mange, Adam Frank, Peter Abt, Niraj M Desai

Transplantation· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early kidney dysfunction post liver transplantation predicts late chronic kidney disease.
Ergun Velidedeoglu, Roy D Bloom, Michael D Crawford, Niraj M Desai, Luis Campos, Kevin C Mange

Transplantation· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and the survival of renal allografts from living donors.
Kevin C Mange, Harold I Feldman, Marshall M Joffe, Kosunarty Fa, Roy D Bloom

J Am Soc Nephrol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
Niraj M Desai, Kevin C Mange, Michael D Crawford, Peter L Abt, Adam M Frank

Transplantation· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of persons who present for preemptive and nonpreemptive kidney transplantation.
Francis L Weng, Kevin C Mange

Am J Kidney Dis· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis